XCOPRI
XCOPRI
Approved
DIN Number
02538741
Drug Class
Human
Market Date
Nov 20, 2023
Company
HC
Endo Operations Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02538741
AIG Number0164761005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX25 CENOBAMATE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
CENOBAMATEActive
Strength: 150 MG
Monograph: CENOBAMATE